As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

HHS and its agencies "help health care providers and the public learn about and respond to public health incidents and ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

And remember, Medicare provides access to about 8,000 drugs ... but what I will tell you is there is a core of personnel at HHS, regardless of administration, that has done dramatically important ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Under the secretary’s leadership, the multiple agencies that constitute HHS oversee the financing of Medicare and Medicaid, conduct research to improve care quality, monitor health care fraud ...

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...